Cornell researchers have developed a portable diagnostic test that can simultaneously detect and distinguish Ebola and Lassa, two serious viruses whose early symptoms can be difficult to tell apart.

Countable Labs announces Ancora assays for molecular testing of hematologic malignancy, marking the company's entry into clinical markets.

CMS releases preliminary 2027 Medicare lab pay rates showing average 16% decrease based on private insurance data, sparking ...

The Department of Health and Human Services has launched more than 20 initiatives toward those goals during President Donald ...

The Mycotoxin Extensive Panel expands biomarkers to test for 16 additional mycotoxins, making it the most comprehensive ...

Founded in 1982, the Los Angeles-based lab has been trusted for decades by the International Olympic Committee and top sports organizations to test for hundreds of prohibited substances. The ...